Joaquín Martinez-Lopez graduated in Medicine from the University of Granada in 1991 and obtained his doctorate from the Complutense University of Madrid in 2002. In 2010, he earned a fellowship in cellular therapy from the University of Toronto. He has been the head of the hematology department at the Hospital 12 de Octubre in Madrid since 2016, and since 2022, he has been a full professor of Medicine at the Complutense University. Since 2015 he is the director of hematology program at CNIO (the Spanish Cancer Center Research Center) In the last 15 years, he has published more than 400 articles in international scientific journals, some of them in the most prestigious publications (H-Index 73). He has presented more than 1,000 works at scientific meetings, delivered lectures worldwide, and received numerous awards. He is the inventor of 8 patents and has founded 2 biotechnology-based companies in Madrid. Since 2018, he has been a visiting professor at UCSF, San Francisco, and since 2024, he has been an advisor to Qilu Hospital (Shandong University) in China. He is a globally recognized expert in multiple myeloma, myeloproliferative neoplasms, cellular therapy, and the study of measurable residual disease.